MILESTONE SCIENTIFIC INC. (MLSS) Free cash flow
- Free cash flow · 12 months (USD): Value $-657.76K; Formula and calculation Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30..
- Price / free cash flow · 12 months: Value (m); Formula and calculation Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30..
- Free cash flow yield · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30..
- Free cash flow margin · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30..
Free cash flow
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Free cash flow · 12 months (USD) | $-657.76K | Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30. $-642.64K − $15.12K ≈ $-657.76K |
| Price / free cash flow · 12 months | (m) | Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow yield · 12 months | (m) | (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow margin · 12 months | (m) | (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow per share · 12 months | (m) | (Trailing-year operating cash flow − capital spending) / reported quarter-end common shares. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Operating cash flow · 12 months | $-642.64K | Cash generated by operating activities. Period ending 2026-06-30. |
| Operating cash flow / net income · 12 months | -0.09× | Operating cash flow / net income. Period ending 2026-06-30. $-642.64K ÷ $7.30M ≈ -0.09× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating cash flow | -642.64K USD | Net Cash Provided by (Used in) Operating Activities · Net Cash Provided by (Used in) Operating Activities, Continuing Operations |
| Capital spending | 15.12K USD | Payments to Acquire Property, Plant, and Equipment |
| Market cap | (m) | |
| Free cash flow | -657.76K USD | Net Cash Provided by (Used in) Operating Activities · Net Cash Provided by (Used in) Operating Activities, Continuing Operations · Payments to Acquire Property, Plant, and Equipment |
| Revenue | (m) | |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
| Net income | 7.30M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Free cash flow | FCF per share | Operating cash flow | Capital spending (USD) | Market cap (USD) | Revenue (USD) | Quarter-end shares (shares) | Net income (USD) | Price / FCF | FCF yield | FCF margin | Cash conversion |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $-657.76K | (m) | $-642.64K | $15.12K | (m) | (m) | (m) | $7.30M | (m) | (m) | (m) | -0.09× |
| 2026-03-31 | $-1.84M | (m) | $-1.82M | $15.45K | (m) | (m) | (m) | $-4.57M | (m) | (m) | (m) | 0.40× |
| 2025-12-31 | $-2.93M | (m) | $-2.92M | $15.12K | (m) | (m) | (m) | $-5.72M | (m) | (m) | (m) | 0.51× |
| 2025-09-30 | (m) | (m) | $-4.20M | (m) | (m) | (m) | (m) | $-6.67M | (m) | (m) | (m) | 0.63× |
| 2025-06-30 | (m) | (m) | $-5.26M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | (m) | $-2.71M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | (m) | $-2.92M | (m) | (m) | (m) | (m) | $-4.71M | (m) | (m) | (m) | 0.62× |
| 2024-09-30 | (m) | (m) | $-2.65M | (m) | (m) | (m) | (m) | $-4.62M | (m) | (m) | (m) | 0.57× |
| 2024-06-30 | (m) | (m) | $-2.73M | (m) | (m) | (m) | (m) | $-4.62M | (m) | (m) | (m) | 0.59× |
| 2024-03-31 | (m) | (m) | $-4.54M | (m) | (m) | (m) | (m) | $-7.06M | (m) | (m) | (m) | 0.64× |
| 2023-12-31 | (m) | (m) | $-5.33M | (m) | (m) | (m) | (m) | $-6.93M | (m) | (m) | (m) | 0.77× |
| 2023-09-30 | (m) | (m) | $-5.17M | (m) | (m) | (m) | (m) | $-6.96M | (m) | (m) | (m) | 0.74× |
| 2023-06-30 | (m) | (m) | $-5.26M | (m) | (m) | (m) | (m) | $-7.47M | (m) | (m) | (m) | 0.70× |
| 2023-03-31 | $-6.54M | (m) | $-6.53M | $9.72K | (m) | (m) | (m) | $-8.11M | (m) | (m) | (m) | 0.80× |
| 2022-12-31 | $-6.04M | (m) | $-6.03M | $8.53K | (m) | (m) | (m) | $-8.71M | (m) | (m) | (m) | 0.69× |
| 2022-09-30 | $-5.33M | (m) | $-5.33M | $-470.00 | (m) | (m) | (m) | $-7.85M | (m) | (m) | (m) | 0.68× |
| 2022-06-30 | (m) | (m) | $-5.75M | (m) | (m) | (m) | (m) | $-7.93M | (m) | (m) | (m) | 0.73× |
| 2022-03-31 | $-4.57M | (m) | $-4.56M | $9.27K | (m) | (m) | (m) | $-7.75M | (m) | (m) | (m) | 0.59× |
| 2021-12-31 | $-4.03M | (m) | $-4.02M | $15.19K | (m) | (m) | (m) | $-6.82M | (m) | (m) | (m) | 0.59× |
| 2021-09-30 | $-4.29M | (m) | $-4.27M | $19.49K | (m) | (m) | (m) | $-6.78M | (m) | (m) | (m) | 0.63× |
| 2021-06-30 | $-4.96M | (m) | $-4.94M | $19.01K | (m) | (m) | (m) | $-6.22M | (m) | (m) | (m) | 0.79× |
| 2021-03-31 | $-7.00M | (m) | $-6.98M | $20.22K | (m) | (m) | (m) | $-6.71M | (m) | (m) | (m) | 1.04× |
| 2020-12-31 | $-7.01M | (m) | $-6.98M | $21.44K | (m) | (m) | (m) | $-7.34M | (m) | (m) | (m) | 0.95× |
| 2020-09-30 | $-6.87M | (m) | $-6.85M | $21.44K | (m) | (m) | (m) | $-9.12M | (m) | (m) | (m) | 0.75× |
| 2020-06-30 | $-5.29M | (m) | $-5.27M | $17.31K | (m) | (m) | (m) | $-10.47M | (m) | (m) | (m) | 0.50× |
| 2020-03-31 | $-2.54M | (m) | $-2.53M | $8.95K | (m) | (m) | (m) | $-8.34M | (m) | (m) | (m) | 0.30× |
| 2019-12-31 | $-1.79M | (m) | $-1.78M | $9.92K | (m) | (m) | (m) | $-7.52M | (m) | (m) | (m) | 0.24× |
| 2019-09-30 | $-957.00K | (m) | $-946.19K | $10.81K | (m) | (m) | (m) | $-4.48M | (m) | (m) | (m) | 0.21× |
| 2019-06-30 | (m) | (m) | $-733.61K | (m) | (m) | (m) | (m) | $-6.04M | (m) | (m) | (m) | 0.12× |
| 2019-03-31 | $-1.32M | (m) | $-1.31M | $14.14K | (m) | (m) | (m) | $-6.34M | (m) | (m) | (m) | 0.21× |
| 2018-12-31 | $-1.64M | (m) | $-1.63M | $7.40K | (m) | (m) | (m) | $-7.43M | (m) | (m) | (m) | 0.22× |
| 2018-09-30 | $-1.63M | (m) | $-1.63M | $7.76K | (m) | (m) | (m) | $-9.40M | (m) | (m) | (m) | 0.17× |
| 2018-06-30 | (m) | (m) | $-1.79M | (m) | (m) | (m) | (m) | $-6.42M | (m) | (m) | (m) | 0.28× |
| 2018-03-31 | (m) | (m) | $-896.77K | (m) | (m) | (m) | (m) | $-6.56M | (m) | (m) | (m) | 0.14× |
| 2017-12-31 | $-1.24M | (m) | $-1.23M | $6.01K | (m) | (m) | (m) | $-5.19M | (m) | (m) | (m) | 0.24× |
| 2017-09-30 | $-2.84M | (m) | $-2.84M | $5.15K | (m) | (m) | (m) | $-5.14M | (m) | (m) | (m) | 0.55× |
| 2017-06-30 | $-3.33M | (m) | $-3.33M | $3.02K | (m) | (m) | (m) | $-5.55M | (m) | (m) | (m) | 0.60× |
| 2017-03-31 | (m) | (m) | $-4.88M | (m) | (m) | (m) | (m) | $-5.70M | (m) | (m) | (m) | 0.86× |
| 2016-12-31 | $-5.41M | (m) | $-5.40M | $15.34K | (m) | (m) | (m) | $-5.95M | (m) | (m) | (m) | 0.91× |
| 2016-09-30 | $-3.34M | (m) | $-3.30M | $34.91K | (m) | (m) | (m) | $-5.61M | (m) | (m) | (m) | 0.59× |
| 2016-06-30 | $-3.60M | (m) | $-3.56M | $40.83K | (m) | (m) | (m) | $-5.35M | (m) | (m) | (m) | 0.66× |
| 2016-03-31 | $-3.72M | (m) | $-3.65M | $69.98K | (m) | (m) | (m) | $-5.80M | (m) | (m) | (m) | 0.63× |
| 2015-12-31 | $-3.01M | (m) | $-2.95M | $67.58K | (m) | (m) | (m) | $-5.47M | (m) | (m) | (m) | 0.54× |
| 2015-09-30 | $-3.45M | (m) | $-3.38M | $63.69K | (m) | (m) | (m) | $-5.43M | (m) | (m) | (m) | 0.62× |
| 2015-06-30 | $-2.31M | (m) | $-2.20M | $103.44K | (m) | (m) | (m) | $-4.22M | (m) | (m) | (m) | 0.52× |
| 2015-03-31 | $-661.23K | (m) | $-581.22K | $80.02K | (m) | (m) | (m) | $-2.32M | (m) | (m) | (m) | 0.25× |
| 2014-12-31 | $294.73K | (m) | $376.94K | $82.21K | (m) | (m) | (m) | $-1.70M | (m) | (m) | (m) | -0.22× |
| 2014-09-30 | $744.74K | (m) | $813.30K | $68.56K | (m) | (m) | (m) | $688.54K | (m) | (m) | (m) | 1.18× |
| 2014-06-30 | $1.40M | (m) | $1.42M | $23.94K | (m) | (m) | (m) | $1.27M | (m) | (m) | (m) | 1.12× |
| 2014-03-31 | $1.61M | (m) | $1.62M | $9.30K | (m) | (m) | (m) | $1.51M | (m) | (m) | (m) | 1.07× |
| 2013-12-31 | $1.25M | (m) | $1.26M | $5.54K | (m) | (m) | (m) | $1.46M | (m) | (m) | (m) | 0.86× |
| 2013-09-30 | $335.78K | (m) | $339.57K | $3.79K | (m) | (m) | (m) | $77.54K | (m) | (m) | (m) | 4.38× |
| 2013-06-30 | $62.56K | (m) | $67.47K | $4.91K | (m) | (m) | (m) | $-125.83K | (m) | (m) | (m) | -0.54× |
| 2013-03-31 | (m) | (m) | $-10.20K | (m) | (m) | (m) | (m) | $-364.38K | (m) | (m) | (m) | 0.03× |
| 2012-12-31 | $-54.45K | (m) | $-49.72K | $4.74K | (m) | (m) | (m) | $-870.31K | (m) | (m) | (m) | 0.06× |
| 2012-09-30 | $-221.47K | (m) | $-216.20K | $5.26K | (m) | (m) | (m) | $-909.62K | (m) | (m) | (m) | 0.24× |
| 2012-06-30 | $-158.52K | (m) | $-154.70K | $3.81K | (m) | (m) | (m) | $-1.56M | (m) | (m) | (m) | 0.10× |
| 2012-03-31 | (m) | (m) | $-211.52K | (m) | (m) | (m) | (m) | $-1.70M | (m) | (m) | (m) | 0.12× |
| 2011-12-31 | $-578.20K | (m) | $-570.73K | $7.47K | (m) | (m) | (m) | $-1.48M | (m) | (m) | (m) | 0.39× |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $-323.13K | (m) | $-293.78K | $29.36K | (m) | (m) | (m) | $-614.51K | (m) | (m) | (m) | 0.48× |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lifeward Ltd. (LFWD) | $0.021B | ||
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| ENvue Medical, Inc. (FEED) | United States | $0.011B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| Bone Biologics Corp (BBLG) | United States | $0.001B | |
| LogicMark, Inc. (LGMK) | United States | $0.000B | |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| NutriBand Inc. (NTRB) | United States | $0.109B |